Genetics determines cannabis potency, flavor, and therapeutic value. Choose the right cultivar, stabilize the right traits, and the chemistry will follow. But a new in-depth biological study suggests that genetics may be only part of the equation. A recent study published in Frontiers in Plant Science [...]
Economist, Beau Whitney, released a report on the 2024 Cannabis Business Conditions and Sentiment Survey. It states that the legal cannabis industry remains structurally unprofitable for most operators—an issue that disproportionately impacts social equity entrepreneurs. The survey found that only 27.3 percent of U.S. cannabis businesses [...]
There is a growing fear among New York cannabis operators that the lawsuit challenging Metrc’s Retail ID program will “kill track and trace” and return the state to the chaos of inversion and inventory failures experienced last year. That fear is understandable. It is also wrong. [...]
For cannabis operators, the cost of goods sold (COGS) is far more than an accounting line item. It’s the most critical financial number in the entire business. Under IRC Section 280E, most ordinary business deductions are disallowed, making COGS the primary mechanism for reducing taxable income. [...]
The cannabis industry is still operating within a cobbled-together financial system—one defined by workarounds, instability, and uncertainty. Most major banks remain unwilling to work with cannabis businesses due to the risk and compliance burdens associated with serving a federally illegal industry. In 2014, former Safe Harbor [...]
For years, cannabis executives have built their financial strategies around a single hope: that Section 280E would vanish with federal reform. But hope has quietly drained billions from balance sheets. Every year, operators “wait it out”; they forfeit the one thing they can’t afford to lose, [...]
It is not uncommon for industries outside cannabis to adapt their technologies to address challenges unique to this maturing sector. American Air Filter International (AFF) is one such company, bringing decades of experience in air filtration for critical environments such as pharmaceutical clean rooms, food manufacturing [...]
When a new cannabis business starts hiring, the focus is usually on speed. You need people to pack, label, deliver, and sell. Payroll and HR often come later—until a compliance notice, tax penalty, or angry employee forces attention. By that point, “later” has turned into a [...]
NASA’s core mission is to explore space and aeronautics, expand scientific knowledge, develop breakthrough technologies, and ultimately bring new knowledge and opportunity back to Earth. What many people do not realize is that some of NASA’s most impactful discoveries have reshaped industries far beyond aerospace, including [...]
Not every genetic is suited for every growing environment, production model, or end market. For cultivators, the challenge is not finding new genetics but identifying which breeders align with their goals and whether those genetics are clean, stable, and commercially viable. As demand grows for consistency, [...]
As the cannabis industry continues to mature, labeling will continue to shape the way for product identification and consumer safety. Looking ahead to 2026, cannabis businesses face growing pressure to improve accuracy, strengthen compliance, streamline production, and build trust with both regulators and consumers. The most [...]
For more than a decade, the cannabis industry has been stuck in a state of contradictions: fully legal in many states and fully illegal at the federal level. When it comes to finances, the result is a sector with modern retail expectations supported by armored cars, [...]
A decade ago, most banks wouldn’t touch a cannabis business. Whenever banking access came up, the discussion stopped almost immediately. People said it was too risky, too unclear, or that the timing just wasn’t right. Today, Green Check has over 180 financial institutions across the U.S. [...]
Below are excerpts from the conversation at the White House press conference where President Trump signed an Executive Order to move marijuana from a Schedule 1 controlled drug to Schedule III. President Trump: Well, it was a big day, and many reasons, really, for many reasons, [...]
The moment many in the cannabis industry have been waiting for has finally arrived. Operators, investors, and advocates are cautiously celebrating President Trump’s executive order directing the Department of Justice to finalize the rescheduling of cannabis to Schedule III, an action many hope is a stepping [...]
81% of consumers need to trust a brand before they’ll even consider buying from it. But what happens when your industry is built on a shaky foundation—one full of stigma, skepticism, or confusion? That’s cannabis. And yet, some of the sharpest, most strategic brand-building I’ve seen [...]
In cannabis cultivation today, many decisions are made in response to market pressures such as speed, yield, and potency. But after two decades in both cannabis cultivation and commercial horticulture, I’ve come to believe that the most valuable outcomes, both for consumers and cultivators, are the [...]
Minnesota has one of the most progressive markets in the US to normalize cannabis. Liquor stores can sell certain hemp-derived THC products, and restaurants are serving THC drinks on tap if they obtain the appropriate registration or license. They are also introducing new ways to roll [...]
Social equity in cannabis looks different in every state. At MJBizCon, the people working hardest to open doors for others came together to trade insights and discuss what it really takes to succeed and get a leg up. Kicking off the session was Cash Color Cannabis [...]
Cutting cultivation costs was one of the loudest themes at this year’s MJBizCon. Michigan cultivator Kevin Kuethe, Chief Cultivation Officer at Lume, shared his strategy for combating price compression through genetics during a panel discussion titled “Mastering Genetics.” “The easiest way to do that is through [...]
As the industry clings to the hope of rescheduling, legal chaos continues to intensify after Congress moved to close the hemp loophole. The new language, set to take effect next October, has many hemp beverage and edible companies scrambling for a Plan B. While the intent [...]
The path cannabis is on isn’t new. The craft beer world walked it first, turning small, hands-on operations into efficient producers without losing their character. The lesson then, as now, was that passion alone doesn’t scale. Craft beer’s early boom wasn’t just cultural, it was operational. [...]
The experience in both wine and cannabis starts with ritual: swirling, inhaling, letting heat or air coax the plant’s chemistry to life. Where wine has long relied on sommeliers to guide that moment, cannabis has spent decades without an equivalent voice to explain how cultivation, curing, [...]
In cannabis, everything begins with genetics. Before lighting, curing, irrigation, or any cultivation technique, there is the seed. And within that seed lives more than chemistry. It holds history, culture, and potential. Genetics are the soul of cannabis. They determine whether a cultivar expresses citrus or [...]
Banking for cannabis businesses has come a long way. Ten years ago, most banks wouldn’t even consider it. Conversations would stop almost as soon as they began. “Too risky,” they’d say. “Too unclear.” Or, “Maybe someday, but not now.” Fast forward to today, and Green Check [...]
The recent Business of Cannabis Summit in New York City brought together industry professionals at the trendy Wythe Hotel in Williamsburg, Brooklyn, for a day focused on tackling the cannabis industry’s toughest challenges: price compression, retail survival, and the slow but steady shift from legacy to [...]
With shifting perceptions, economic incentives, and the evolution of international regulatory frameworks, more countries around the world are starting to embrace legal cannabis for its medical and recreational uses. One of the hotspots of legalization remains the European Union, where countries like Malta and Luxembourg have [...]
Most cannabis operators I meet are juggling a lot more than they expected. One day they’re handling payroll, the next they’re sorting out compliance, and somehow still trying to grow the business. HR usually gets squeezed somewhere in between. It’s not that owners don’t care about [...]
There was no more fitting venue for a cannabis industry gathering than the Museum of the American Revolution in Philadelphia. The historic setting served as the backdrop for the Accelerate Cannabis Summit, a groundbreaking event that brought together cannabis leaders, entrepreneurs, and government officials from across [...]
A panel discussion at the recent Business of Cannabis event in NYC analyzed the serious issues still facing the industry rollout in New York. What has been touted as a social equity-first initiative has been riddled with significant challenges and lawsuits. To date, the Office of [...]
For the first time, cannabis brands can claim airtime right alongside household names like Nike and Home Depot. Streaming platforms are serving Fortune 500 advertisers every hour, and now compliant cannabis companies are joining the lineup. This article breaks down how Connected TV (CTV) unlocks new [...]
The highlight of the Business of Cannabis event, held at the Wythe Hotel in Williamsburg, a hip neighborhood in Brooklyn, New York, was the keynote speaker. Ethan Nadelmann, founder of the Drug Policy Alliance, has since retired from his position but continues to mentor and serve [...]
This has been a whirlwind year in Washington, D.C., with the inauguration of President Donald Trump and the swearing in of a new Republican majority in the U.S. Senate. The “Republican trifecta” of the House, Senate, and administration has led to stalled progress with cannabis legalization, [...]
At the recent Business of Cannabis event in New York, Robert Sciarrone, Chief Revenue Officer at Curaleaf, shared an MSO’s insider view on why he believes New York is poised to become the best cannabis market on the planet. Sciarrone began by reflecting on his early [...]
Cannabis products are increasingly held to the same standards as food and pharmaceuticals, and that means verifying how their potency and composition change over time. Cannabis stability testing provides the data needed to establish reliable shelf life, confirm product consistency, and guide formulation optimization for improved [...]
As cannabis production scales and testing standards tighten, cultivators face increasing pressure to ensure their products are free from harmful microbes without compromising quality. Decontamination, the process of removing or killing microorganisms, has become a common step in post-harvest processing. Traditional methods come with trade-offs that [...]
MariMed, one of the nation’s leading multi-state cannabis operators, began in the medical cannabis market and expanded into adult-use as states legalized. Through this growth, the company has remained true to its “medical-first” approach, ensuring that product quality, safety, and consistency remain at the core of [...]
For decades, cannabis has lived in a research dead zone. Federal prohibition has blocked meaningful grants, limited clinical trials, and left millions of people with cancer relying on anecdotal evidence for treatment rather than data. As founders of E.R.I.C. Cancer Playbook, we refused to accept that. [...]
Jason Ambrosino, a disabled Army veteran and founder of Veterans Holdings, entered the New York market in 2019 under the state’s hemp program with the goal of cultivating and manufacturing cannabis. But despite holding a 5,000-square-foot indoor cultivation license, he decided not to build out his [...]
A new health-tech company, EM2P2, has launched CannaLnx, a HIPAA-compliant platform it claims will make medical cannabis reimbursable under traditional health insurance plans for the first time in the U.S. The system, announced in partnership with the American Council of Cannabis Medicine (ACCM), is described as [...]
Most cannabis dispensaries are small businesses. That often means they operate on tight margins and require employees to take on roles outside their typical job descriptions. It’s common for owners or general managers to handle HR and payroll functions themselves. What begins as an understandable cost-saving measure, however, [...]
Multiple scientific studies and lab results have provided compelling evidence that terpenes and volatile metabolites in cannabis rapidly degrade when exposed to light, oxygen, heat, and time, and therefore, reduce the entourage effect that depends on a specific balance of cannabinoids and terpenes. Because of this, [...]
Target’s decision to start selling hemp-derived THC beverages marks a major milestone for the cannabis industry and a reality check for brands hoping to follow. Selling into mass retail is not just about scaling production or packaging appeal. It requires proving that your product meets the [...]
In cannabis, it sometimes feels like every financial conversation ends the same way: “If not for 280E, we’d be thriving.” That line gets repeated in boardrooms and investor decks across the country, and for good reason. Section 280E has choked margins, slowed growth, and kept great [...]
Global cannabis trade is well underway as legalized countries move forward to establish a supply chain infrastructure in a newly formed and rapidly evolving industry. At the forefront of transportation logistics is Cannabilog, an Israeli company led by pharmaceutical industry veteran Yoram Eshel. In an interview, [...]
As our bodies age, the mechanisms that keep our systems humming, such as immune regulation, metabolism, and neural repair, gradually erode. That loss of homeostasis is the culprit behind many age-related disorders, from cognitive decline to metabolic dysfunction. Scientists are beginning to explore whether cannabis or [...]
Q&A with Brendan McGee, Founder, Silver Therapeutics Tell us about your product(s). What do you make or sell, and what should people know about it? At Silver Therapeutics, we’re driven to curate experiences that meet people where they are. From flower to prerolls to vapes, we [...]
Alibi Cannabis website. Q&A Tell us about your product(s). What do you make or sell, and what should people know about it? Our roots are in cultivation, so everything starts with high-quality flowers. In Oregon, our flower has won multiple awards, and we bring that focus [...]
Website: rosareta.com Tell us about your product(s). What do you make or sell, and what should people know about it? Rosa Reta crafts solventless cannabis Live Rosin vapes (All-In-One), Bubble Hash Infused prerolls, and Rosin infused gummies. We focus on clean processing, full-spectrum flavor, and consistent quality [...]
The cannabis industry’s fragmented foundation is creating a host of problems tied to the lack of federal legalization. Many experts believe that without a national medical cannabis framework, the future of cannabis as a medicine in America could leave patients unprotected, research underfunded, and the industry [...]
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
